Acyldepsipeptide Analogues: A Future Generation Antibiotics for Tuberculosis Treatment

Acyldepsipeptide Analogues: A Future Generation Antibiotics for Tuberculosis Treatment

Acyldepsipeptides (ADEPs) are a new class of emerging antimicrobial peptides (AMPs), which are currently explored for treatment of pathogenic infections, including tuberculosis (TB). These cyclic hydrophobic peptides have a unique bacterial target to the conventional anti-TB drugs, and present a the...

Full description

Bibliographic Details
Main Authors: Sinazo Z. Z. Cobongela, Maya M. Makatini, Phumlane S. Mdluli, Nicole R. S. Sibuyi
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Pharmaceutics
Subjects:
acyldepsipeptides
antimicrobial peptides
caseinolytic protease
<i>Mycobacterium tuberculosis</i>
antimicrobial
tuberculosis
Online Access:https://www.mdpi.com/1999-4923/14/9/1956

Similar Items

Similar Items